[1] Supuran C T. Carbonic anhydrases——an overview. Curr Pharm Des, 2008, 14(7):603-614.
[2] Parissa M, Koorosh A, Nader M. Investigating the application of enzyme carbonic anhydrase for CO2 sequestration purposes. Ind Eng Chem Res, 2007, 46(3):921-926.
[3] Ramanan R, Kannan K, Sivanesan S D, et al. Bio-sequestration of carbon dioxide using carbonic anhydrase enzyme purified from Citrobacter freundii. World J Microbiol Biotechnol, 2009, 25(6):981-987.
[4] Boskey A L, Posner A S. Bone structure, composition, and mineralization. Orthop Clin North Am, 1984, 15(4):597-612.
[5] Zhang X, Aubin J E, Inman R D. Molecular and cellular biology of new bone formation: insights into the ankylosis of ankylosing spondylitis. Curr Opin Rheumatol, 2003, 15(4):387-393.
[6] Schett G. Bone formation versus bone resorption in ankylosing spondylitis. Adv Exp Med Biol, 2009, 649:114-121.
[7] Grisar J, Bernecker P M, Aringer M, et al. Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. J Rheumatol, 2002, 29(7):1430-1436.
[8] Van der Horst-Bruinsma I E, Lems W F, Dijkmans B A. A systematic comparison of rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol, 2009, 27(4):S43-S49.
[9] Chen W S, Chen C H, Lin K C, et al. Immunohistological features of hip synovitis in ankylosing spondylitis with advanced hip involvement. Scand J Rheumatol, 2009, 38(2):154-155.
[10] Chang X, Zhao Y, Yan X, et al. Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis. BMC Musculoskeletal Disorders, 2010, 11:279.
[11] Bielby R C, Boccaccini A R, Polak J M, et al. In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng, 2004, 10(9-10):1518-1525.
[12] Stanford C M, Jacobson P A, Eanes E D, et al. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem, 1995, 270(16):9420-9428.
[13] Thouverey C, Strzelecka-Kiliszek A, Balcerzak M, et al. Matrix vesicles originate from apical membrane microvilli of mineralizing osteoblast-like Saos-2 cells. J Cell Biochem, 2009, 106(1):127-138.
[14] Gregory C A, Gunn W G, Peister A, et al. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem, 2004, 329(1):77-84.
[15] Heng N H, N’Guessan P D, Kleber B M, et al. Enamel matrix derivative induces connective tissue growth factor expression in human osteoblastic cells. J Periodontol, 2007, 78(12):2369-2379.
[16] Igarashi M, Kamiya N, Hasegawa M, et al. Inductive effects of dexamethasone on the gene expression of Cbfa1, Osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts. J Mol Histol, 2004, 35(1):3-10.
[17] Thouverey C, Bleicher F, Bandorowicz-Pikula J. Extracellular ATP and its effects on physiological and pathological mineralization. Curr Opin Orthop, 2007, 18(5):460-466.
[18] Huitema L F, Vaandrager A B. What triggers cell-mediated mineralization? Front Biosci, 2007, 12(1):2631-2645.
[19] Anderson H C. Osteogenetic epithelial-mesenchymal cell interactions. Clin Orthop Relat Res, 1976, 9(119):211-213.
[20] Chang X, Yan X, Zhang Y. Treat ankylosing spondylitis with methazolamide. Int J Med Sci, 2011, 8(5):413-419.
[21] Sauer G R, Genge B R, Wu L N, et al. A facilitative role for carbonic anhydrase activity in matrix vesicle mineralization. Bone Miner, 1994, 26(1):69-79.
[22] Park J B. The effects of dexamethasone, ascorbic acid, and β-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression. J Surg Res, 2010, 10(8):1-10.
|